COGNEX CORP (CGNX) Fundamental Analysis & Valuation

NASDAQ:CGNX • US1924221039

Current stock price

53.41 USD
-0.5 (-0.93%)
At close:
53.41 USD
0 (0%)
After Hours:

This CGNX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. CGNX Profitability Analysis

1.1 Basic Checks

  • CGNX had positive earnings in the past year.
  • In the past year CGNX had a positive cash flow from operations.
  • Each year in the past 5 years CGNX has been profitable.
  • CGNX had a positive operating cash flow in each of the past 5 years.
CGNX Yearly Net Income VS EBIT VS OCF VS FCFCGNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • CGNX has a better Return On Assets (5.68%) than 75.81% of its industry peers.
  • With a decent Return On Equity value of 7.67%, CGNX is doing good in the industry, outperforming 62.10% of the companies in the same industry.
  • CGNX has a Return On Invested Capital of 6.36%. This is in the better half of the industry: CGNX outperforms 66.13% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CGNX is below the industry average of 8.20%.
  • The 3 year average ROIC (5.20%) for CGNX is below the current ROIC(6.36%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.68%
ROE 7.67%
ROIC 6.36%
ROA(3y)5.54%
ROA(5y)8.32%
ROE(3y)7.4%
ROE(5y)11.35%
ROIC(3y)5.2%
ROIC(5y)7.78%
CGNX Yearly ROA, ROE, ROICCGNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With an excellent Profit Margin value of 11.51%, CGNX belongs to the best of the industry, outperforming 86.29% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CGNX has declined.
  • Looking at the Operating Margin, with a value of 16.35%, CGNX belongs to the top of the industry, outperforming 91.94% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CGNX has declined.
  • Looking at the Gross Margin, with a value of 66.92%, CGNX belongs to the top of the industry, outperforming 97.58% of the companies in the same industry.
  • CGNX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 16.35%
PM (TTM) 11.51%
GM 66.92%
OM growth 3Y-15.08%
OM growth 5Y-8.44%
PM growth 3Y-18.7%
PM growth 5Y-11.93%
GM growth 3Y-2.3%
GM growth 5Y-2.14%
CGNX Yearly Profit, Operating, Gross MarginsCGNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

9

2. CGNX Health Analysis

2.1 Basic Checks

  • CGNX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for CGNX has been reduced compared to 1 year ago.
  • Compared to 5 years ago, CGNX has less shares outstanding
  • There is no outstanding debt for CGNX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CGNX Yearly Shares OutstandingCGNX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
CGNX Yearly Total Debt VS Total AssetsCGNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 11.64 indicates that CGNX is not in any danger for bankruptcy at the moment.
  • CGNX's Altman-Z score of 11.64 is amongst the best of the industry. CGNX outperforms 88.71% of its industry peers.
  • CGNX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.64
ROIC/WACC0.66
WACC9.57%
CGNX Yearly LT Debt VS Equity VS FCFCGNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 3.80 indicates that CGNX has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.80, CGNX is in the better half of the industry, outperforming 70.16% of the companies in the same industry.
  • CGNX has a Quick Ratio of 3.05. This indicates that CGNX is financially healthy and has no problem in meeting its short term obligations.
  • CGNX has a better Quick ratio (3.05) than 72.58% of its industry peers.
Industry RankSector Rank
Current Ratio 3.8
Quick Ratio 3.05
CGNX Yearly Current Assets VS Current LiabilitesCGNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

5

3. CGNX Growth Analysis

3.1 Past

  • CGNX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.49%, which is quite impressive.
  • Measured over the past years, CGNX shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.77% on average per year.
  • CGNX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.73%.
  • Measured over the past years, CGNX shows a small growth in Revenue. The Revenue has been growing by 4.16% on average per year.
EPS 1Y (TTM)36.49%
EPS 3Y-8.3%
EPS 5Y-0.77%
EPS Q2Q%35%
Revenue 1Y (TTM)8.73%
Revenue growth 3Y-0.39%
Revenue growth 5Y4.16%
Sales Q2Q%9.86%

3.2 Future

  • Based on estimates for the next years, CGNX will show a very strong growth in Earnings Per Share. The EPS will grow by 22.78% on average per year.
  • Based on estimates for the next years, CGNX will show a small growth in Revenue. The Revenue will grow by 1.76% on average per year.
EPS Next Y26.23%
EPS Next 2Y24.02%
EPS Next 3Y17.04%
EPS Next 5Y22.78%
Revenue Next Year9.09%
Revenue Next 2Y8.9%
Revenue Next 3Y9.74%
Revenue Next 5Y1.76%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CGNX Yearly Revenue VS EstimatesCGNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
CGNX Yearly EPS VS EstimatesCGNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2

3

4. CGNX Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 52.88, CGNX can be considered very expensive at the moment.
  • CGNX's Price/Earnings is on the same level as the industry average.
  • CGNX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.78.
  • A Price/Forward Earnings ratio of 41.89 indicates a quite expensive valuation of CGNX.
  • CGNX's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of CGNX to the average of the S&P500 Index (23.54), we can say CGNX is valued expensively.
Industry RankSector Rank
PE 52.88
Fwd PE 41.89
CGNX Price Earnings VS Forward Price EarningsCGNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • CGNX's Enterprise Value to EBITDA is on the same level as the industry average.
  • CGNX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CGNX is cheaper than 66.94% of the companies in the same industry.
Industry RankSector Rank
P/FCF 37.67
EV/EBITDA 44.44
CGNX Per share dataCGNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • CGNX has a very decent profitability rating, which may justify a higher PE ratio.
  • CGNX's earnings are expected to grow with 17.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.02
PEG (5Y)N/A
EPS Next 2Y24.02%
EPS Next 3Y17.04%

4

5. CGNX Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.71%, CGNX is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.46, CGNX pays a better dividend. On top of this CGNX pays more dividend than 82.26% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, CGNX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.71%

5.2 History

  • The dividend of CGNX decreases each year by -32.10%.
  • CGNX has paid a dividend for at least 10 years, which is a reliable track record.
  • CGNX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-32.1%
Div Incr Years4
Div Non Decr Years4
CGNX Yearly Dividends per shareCGNX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 47.73% of the earnings are spent on dividend by CGNX. This is a bit on the high side, but may be sustainable.
DP47.73%
EPS Next 2Y24.02%
EPS Next 3Y17.04%
CGNX Yearly Income VS Free CF VS DividendCGNX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
CGNX Dividend Payout.CGNX Dividend Payout, showing the Payout Ratio.CGNX Dividend Payout.PayoutRetained Earnings

CGNX Fundamentals: All Metrics, Ratios and Statistics

COGNEX CORP

NASDAQ:CGNX (4/10/2026, 8:11:51 PM)

After market: 53.41 0 (0%)

53.41

-0.5 (-0.93%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-11
Earnings (Next)04-30
Inst Owners103.96%
Inst Owner Change0%
Ins Owners0.3%
Ins Owner Change1.46%
Market Cap8.92B
Revenue(TTM)994.36M
Net Income(TTM)114.44M
Analysts77.93
Price Target66.1 (23.76%)
Short Float %2.4%
Short Ratio1.69
Dividend
Industry RankSector Rank
Dividend Yield 0.71%
Yearly Dividend0.32
Dividend Growth(5Y)-32.1%
DP47.73%
Div Incr Years4
Div Non Decr Years4
Ex-Date02-26
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.94%
Min EPS beat(2)11.87%
Max EPS beat(2)20%
EPS beat(4)4
Avg EPS beat(4)13.62%
Min EPS beat(4)3.71%
Max EPS beat(4)20%
EPS beat(8)8
Avg EPS beat(8)17.01%
EPS beat(12)12
Avg EPS beat(12)18.03%
EPS beat(16)14
Avg EPS beat(16)15.8%
Revenue beat(2)2
Avg Revenue beat(2)3.4%
Min Revenue beat(2)3.29%
Max Revenue beat(2)3.51%
Revenue beat(4)2
Avg Revenue beat(4)1.37%
Min Revenue beat(4)-0.78%
Max Revenue beat(4)3.51%
Revenue beat(8)4
Avg Revenue beat(8)0.87%
Revenue beat(12)7
Avg Revenue beat(12)1.04%
Revenue beat(16)9
Avg Revenue beat(16)0.69%
PT rev (1m)0.24%
PT rev (3m)35.54%
EPS NQ rev (1m)0.16%
EPS NQ rev (3m)30.36%
EPS NY rev (1m)10.31%
EPS NY rev (3m)9.24%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)7.87%
Revenue NY rev (1m)0.65%
Revenue NY rev (3m)1.87%
Valuation
Industry RankSector Rank
PE 52.88
Fwd PE 41.89
P/S 8.97
P/FCF 37.67
P/OCF 36.33
P/B 5.98
P/tB 8.71
EV/EBITDA 44.44
EPS(TTM)1.01
EY1.89%
EPS(NY)1.27
Fwd EY2.39%
FCF(TTM)1.42
FCFY2.65%
OCF(TTM)1.47
OCFY2.75%
SpS5.95
BVpS8.93
TBVpS6.13
PEG (NY)2.02
PEG (5Y)N/A
Graham Number14.25
Profitability
Industry RankSector Rank
ROA 5.68%
ROE 7.67%
ROCE 8.87%
ROIC 6.36%
ROICexc 7.79%
ROICexgc 11.33%
OM 16.35%
PM (TTM) 11.51%
GM 66.92%
FCFM 23.81%
ROA(3y)5.54%
ROA(5y)8.32%
ROE(3y)7.4%
ROE(5y)11.35%
ROIC(3y)5.2%
ROIC(5y)7.78%
ROICexc(3y)6.25%
ROICexc(5y)9.59%
ROICexgc(3y)9.12%
ROICexgc(5y)12.58%
ROCE(3y)7.25%
ROCE(5y)10.86%
ROICexgc growth 3Y-13.1%
ROICexgc growth 5Y-4.48%
ROICexc growth 3Y-17.85%
ROICexc growth 5Y-7.32%
OM growth 3Y-15.08%
OM growth 5Y-8.44%
PM growth 3Y-18.7%
PM growth 5Y-11.93%
GM growth 3Y-2.3%
GM growth 5Y-2.14%
F-Score8
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 28.39%
Cap/Sales 0.88%
Interest Coverage 250
Cash Conversion 126.97%
Profit Quality 206.89%
Current Ratio 3.8
Quick Ratio 3.05
Altman-Z 11.64
F-Score8
WACC9.57%
ROIC/WACC0.66
Cap/Depr(3y)59.96%
Cap/Depr(5y)71.35%
Cap/Sales(3y)1.76%
Cap/Sales(5y)1.75%
Profit Quality(3y)137.49%
Profit Quality(5y)124.59%
High Growth Momentum
Growth
EPS 1Y (TTM)36.49%
EPS 3Y-8.3%
EPS 5Y-0.77%
EPS Q2Q%35%
EPS Next Y26.23%
EPS Next 2Y24.02%
EPS Next 3Y17.04%
EPS Next 5Y22.78%
Revenue 1Y (TTM)8.73%
Revenue growth 3Y-0.39%
Revenue growth 5Y4.16%
Sales Q2Q%9.86%
Revenue Next Year9.09%
Revenue Next 2Y8.9%
Revenue Next 3Y9.74%
Revenue Next 5Y1.76%
EBIT growth 1Y41.28%
EBIT growth 3Y-15.41%
EBIT growth 5Y-4.63%
EBIT Next Year44.39%
EBIT Next 3Y27.01%
EBIT Next 5Y24.18%
FCF growth 1Y76.64%
FCF growth 3Y1.91%
FCF growth 5Y0.66%
OCF growth 1Y64.69%
OCF growth 3Y0.29%
OCF growth 5Y0.26%

COGNEX CORP / CGNX Fundamental Analysis FAQ

What is the fundamental rating for CGNX stock?

ChartMill assigns a fundamental rating of 6 / 10 to CGNX.


What is the valuation status for CGNX stock?

ChartMill assigns a valuation rating of 3 / 10 to COGNEX CORP (CGNX). This can be considered as Overvalued.


How profitable is COGNEX CORP (CGNX) stock?

COGNEX CORP (CGNX) has a profitability rating of 7 / 10.


Can you provide the financial health for CGNX stock?

The financial health rating of COGNEX CORP (CGNX) is 9 / 10.


What is the earnings growth outlook for COGNEX CORP?

The Earnings per Share (EPS) of COGNEX CORP (CGNX) is expected to grow by 26.23% in the next year.